日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The use of mass cytometry (CyTOF) to evaluate the cellular uptake of stable radiopharmaceutical surrogates in single cells: a proof-of-concept study

利用质谱流式细胞术(CyTOF)评估单细胞对稳定放射性药物替代物的摄取:概念验证研究

Gómez-Sánchez, Miguel; Blanco-González, Elisa; Montes-Bayón, María; Behe, Martin; Schibli, Roger; Rioja-Blanco, Elisa

La-[(18/19)F]fluoride complexes: a novel addition to the radiofluorination family

La-[(18/19)F]氟化物配合物:放射性氟化家族的新成员

Behe, Martin; Gruber, Stefan; Li, Cen; Schreckenbach, Georg; Mu, Linjing; Schottelius, Margret; Faizova, Radmila

Advancing towards cancer theragnostic by probing the (225)Ac decay chain with ultra-high-resolution metallic magnetic calorimeter based detectors

利用基于超高分辨率金属磁量热仪的探测器探测(225)Ac衰变链,推进癌症诊疗一体化

Maurer, Kiara; Unger, Daniel; Behe, Martin; Knecht, Andreas; von Schoeler, Katharina; Hengstler, Daniel; Vitova, Tonya; Benešová-Schäfer, Martina; Fleischmann, Andreas; Gastaldo, Loredana; Wängler, Carmen; Enss, Christian; Schacherl, Bianca

(161)Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas

(161)Tb放射免疫疗法治疗CD30阳性淋巴瘤

Rioja-Blanco, Elisa; Banz, Yara; Schlapbach, Christoph; Novak, Urban; Chiorazzo, Tanja; Bertschi, Nicole L; Bernhardt, Peter; Grundler, Pascal V; van der Meulen, Nicholas P; Grzmil, Michal; Schibli, Roger; Behe, Martin

Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands

迈向神奇的放射性子弹:通过减少放射性配体的肾脏滞留来改进靶向放射性核素治疗

de Roode, Kim E; Joosten, Lieke; Behe, Martin

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [(177)Lu]Lu-PP-F11N in humans: the lumed phase 0b study

体内抑制中性内肽酶 1 可提高人体内 [(177)Lu]Lu-PP-F11N 的肿瘤吸收剂量:LUMD 0b 期研究

Rottenburger, Christof; Hentschel, Michael; Fürstner, Markus; McDougall, Lisa; Kottoros, Danijela; Kaul, Felix; Mansi, Rosalba; Fani, Melpomeni; Vija, A Hans; Schibli, Roger; Geistlich, Susanne; Behe, Martin; Christ, Emanuel R; Wild, Damian

Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT)

靶向放射性核素治疗(TRT)和体外放射治疗(EBRT)对癌细胞反应的比较分析

Grzmil, Michal; Boersema, Paul; Sharma, Ashish; Blanc, Alain; Imobersteg, Stefan; Pruschy, Martin; Picotti, Paola; Schibli, Roger; Behe, Martin

A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression

多特异性抗 CD40 DARPin 构建体诱导肿瘤选择性 CD40 活化和肿瘤消退

Nicolò Rigamonti, Niina Veitonmäki, Clara Domke, Sophie Barsin, Sarah Jetzer, Omar Abdelmotaleb, Ralph Bessey, Tamara Lekishvili, Francesca Malvezzi, Mariam Gachechiladze, Martin Behe, Victor Levitsky, Pamela A Trail

EANM guideline on quality risk management for radiopharmaceuticals

EANM关于放射性药物质量风险管理的指南

Gillings, Nic; Hjelstuen, Olaug; Behe, Martin; Decristoforo, Clemens; Elsinga, Philip H; Ferrari, Valentina; Kiss, Oliver C; Kolenc, Petra; Koziorowski, Jacek; Laverman, Peter; Mindt, Thomas L; Ocak, Meltem; Patt, Marianne; Todde, Sergio; Walte, Almut

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

小规模制备放射性药物的现行良好放射性药学实践指南(cGRPP)

Gillings, Nic; Hjelstuen, Olaug; Ballinger, Jim; Behe, Martin; Decristoforo, Clemens; Elsinga, Philip; Ferrari, Valentina; Peitl, Petra Kolenc; Koziorowski, Jacek; Laverman, Peter; Mindt, Thomas L; Neels, Oliver; Ocak, Meltem; Patt, Marianne; Todde, Sergio